The linac devices market size has grown strongly in recent years. It will grow from $5.48 billion in 2025 to $5.96 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to expansion of cancer treatment infrastructure, rising global cancer incidence, adoption of advanced radiotherapy techniques, increased availability of oncology specialists, improvements in radiation delivery accuracy.
The linac devices market size is expected to see strong growth in the next few years. It will grow to $8.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing investments in precision oncology, growing demand for personalized cancer treatment, advancements in AI-driven radiotherapy planning, expansion of radiotherapy access in emerging markets, rising adoption of compact linac systems. Major trends in the forecast period include increasing adoption of image-guided radiation therapy, rising use of high-energy linac systems, growing integration of ai-based treatment planning, expansion of compact and modular linac designs, enhanced focus on precision dose delivery.
The increasing prevalence of cancer is expected to drive the growth of the LINAC devices market in the coming years. Cancer prevalence refers to the total number of individuals, including both newly diagnosed and previously diagnosed patients, who are living with a history of cancer at a given point in time. The prevalence of cancer is rising due to lifestyle-related risk factors such as unhealthy diets, smoking, alcohol consumption, and exposure to environmental pollutants, which increase the likelihood of developing various types of cancer. LINAC devices aid in cancer management by delivering precise, high-energy radiation beams that accurately target tumors while minimizing damage to surrounding healthy tissues. These devices enhance treatment precision, improve patient outcomes, and support advanced radiotherapy techniques for more effective cancer treatment. For example, in February 2025, according to Cancer Australia, an Australia-based government agency, there were 4,641 new cases of pancreatic cancer reported in 2024, including 2,414 cases in males and 2,227 cases in females. Therefore, the rising prevalence of cancer is driving the growth of the LINAC devices market.
Technological advancements emerge as a prominent trend in the LINAC devices market, with major companies introducing innovative products such as the ViewRay MRIdian MRI-Guided Radiation Therapy System to maintain their market position. In March 2023, GenesisCare, a US-based provider of cancer and cardiac care, launched an MRI-guided radiation therapy system at the Lee Health Regional Cancer Center. The MRIdian system combines precision radiation therapy with state-of-the-art, high-resolution MRI guidance, potentially reducing the number of treatment sessions required. This technological innovation, exemplified by MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy, marks a significant trend in the LINAC devices market.
In November 2023, AEP Linac, a Netherlands-based manufacturer of magnetrons and thyratrons utilized in (medical) linear accelerators, formed a partnership with Alcare for an undisclosed amount to strengthen its radiation therapy solutions. This collaboration aims to enhance AEP Linac's product offerings by integrating Alcare's expertise in patient care products, ultimately improving the overall treatment experience. Alcare is a Japan-based company known for its innovative solutions that prioritize patient comfort and recovery in medical environments.
Major companies operating in the linac devices market are Elekta AB, Varian Medical Systems Inc, Siemens Healthineers GmbH, Hitachi Ltd, Mitsubishi Heavy Industries Ltd, Sumitomo Heavy Industries Ltd, Shinva Medical Instrument Co Ltd, Huiheng Medical Inc, IBA SA, Mevion Medical Systems Inc, ViewRay Technologies Inc, Advanced Oncotherapy PLC, RefleXion Medical Inc, ProNova Solutions LLC, Panacea Medical Technologies Pvt Ltd, Best Theratronics Ltd, P-Cure Ltd, Accuray Incorporated, CGN Dasheng Electron Accelerator Technology Co Ltd, Nordion Inc, Theragenics Corporation.
North America was the largest region in the LINAC devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global LINAC devices market report during the forecast period. The regions covered in the linac devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the linac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the LINAC devices market by increasing costs of imported accelerator components, imaging subsystems, control electronics, and precision mechanical assemblies used in radiation therapy systems. Hospitals and oncology centers in North America and Europe are most affected due to dependence on imported high-value components, while Asia-Pacific faces cost pressure on LINAC manufacturing and exports. These tariffs are increasing capital expenditure requirements and extending equipment replacement cycles. However, they are also encouraging localized assembly, regional manufacturing investments, and innovation in cost-efficient LINAC system designs.
The linac devices market research report is one of a series of new reports that provides linac devices market statistics, including linac devices industry global market size, regional shares, competitors with a linac devices market share, detailed linac devices market segments, market trends and opportunities, and any further data you may need to thrive in the linac devices industry. This linac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
LINAC stands for linear accelerator, and it refers to a device designed to accelerate charged particles, such as electrons or protons, in a straight line. In medical settings, LINACs are utilized to generate high-energy electron or X-ray beams for radiation therapy, specifically in the treatment of cancer.
The main products of LINAC devices include high-energy, low-energy, and medium-energy devices. A high-energy linear accelerator (LINAC) operates at energies ranging from 20 to 50 million electron volts (MeV). It is used to produce high-energy X-rays or electron beams for radiation therapy, particularly for treating tumors located deep within the body. Linear accelerator and non-dedicated linear accelerator methods are employed in the treatment of various cancers such as breast cancer, colorectal cancer, head and neck cancer, lung cancer, prostate cancer, and others. These devices find application in clinics, hospitals, and research centers.
The LINAC devices market consists of sales of an electron generation component, beam transport equipment, radiotherapy equipment, imaging and monitoring accessory. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The linac devices market size is expected to see strong growth in the next few years. It will grow to $8.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing investments in precision oncology, growing demand for personalized cancer treatment, advancements in AI-driven radiotherapy planning, expansion of radiotherapy access in emerging markets, rising adoption of compact linac systems. Major trends in the forecast period include increasing adoption of image-guided radiation therapy, rising use of high-energy linac systems, growing integration of ai-based treatment planning, expansion of compact and modular linac designs, enhanced focus on precision dose delivery.
The increasing prevalence of cancer is expected to drive the growth of the LINAC devices market in the coming years. Cancer prevalence refers to the total number of individuals, including both newly diagnosed and previously diagnosed patients, who are living with a history of cancer at a given point in time. The prevalence of cancer is rising due to lifestyle-related risk factors such as unhealthy diets, smoking, alcohol consumption, and exposure to environmental pollutants, which increase the likelihood of developing various types of cancer. LINAC devices aid in cancer management by delivering precise, high-energy radiation beams that accurately target tumors while minimizing damage to surrounding healthy tissues. These devices enhance treatment precision, improve patient outcomes, and support advanced radiotherapy techniques for more effective cancer treatment. For example, in February 2025, according to Cancer Australia, an Australia-based government agency, there were 4,641 new cases of pancreatic cancer reported in 2024, including 2,414 cases in males and 2,227 cases in females. Therefore, the rising prevalence of cancer is driving the growth of the LINAC devices market.
Technological advancements emerge as a prominent trend in the LINAC devices market, with major companies introducing innovative products such as the ViewRay MRIdian MRI-Guided Radiation Therapy System to maintain their market position. In March 2023, GenesisCare, a US-based provider of cancer and cardiac care, launched an MRI-guided radiation therapy system at the Lee Health Regional Cancer Center. The MRIdian system combines precision radiation therapy with state-of-the-art, high-resolution MRI guidance, potentially reducing the number of treatment sessions required. This technological innovation, exemplified by MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy, marks a significant trend in the LINAC devices market.
In November 2023, AEP Linac, a Netherlands-based manufacturer of magnetrons and thyratrons utilized in (medical) linear accelerators, formed a partnership with Alcare for an undisclosed amount to strengthen its radiation therapy solutions. This collaboration aims to enhance AEP Linac's product offerings by integrating Alcare's expertise in patient care products, ultimately improving the overall treatment experience. Alcare is a Japan-based company known for its innovative solutions that prioritize patient comfort and recovery in medical environments.
Major companies operating in the linac devices market are Elekta AB, Varian Medical Systems Inc, Siemens Healthineers GmbH, Hitachi Ltd, Mitsubishi Heavy Industries Ltd, Sumitomo Heavy Industries Ltd, Shinva Medical Instrument Co Ltd, Huiheng Medical Inc, IBA SA, Mevion Medical Systems Inc, ViewRay Technologies Inc, Advanced Oncotherapy PLC, RefleXion Medical Inc, ProNova Solutions LLC, Panacea Medical Technologies Pvt Ltd, Best Theratronics Ltd, P-Cure Ltd, Accuray Incorporated, CGN Dasheng Electron Accelerator Technology Co Ltd, Nordion Inc, Theragenics Corporation.
North America was the largest region in the LINAC devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global LINAC devices market report during the forecast period. The regions covered in the linac devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the linac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the LINAC devices market by increasing costs of imported accelerator components, imaging subsystems, control electronics, and precision mechanical assemblies used in radiation therapy systems. Hospitals and oncology centers in North America and Europe are most affected due to dependence on imported high-value components, while Asia-Pacific faces cost pressure on LINAC manufacturing and exports. These tariffs are increasing capital expenditure requirements and extending equipment replacement cycles. However, they are also encouraging localized assembly, regional manufacturing investments, and innovation in cost-efficient LINAC system designs.
The linac devices market research report is one of a series of new reports that provides linac devices market statistics, including linac devices industry global market size, regional shares, competitors with a linac devices market share, detailed linac devices market segments, market trends and opportunities, and any further data you may need to thrive in the linac devices industry. This linac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
LINAC stands for linear accelerator, and it refers to a device designed to accelerate charged particles, such as electrons or protons, in a straight line. In medical settings, LINACs are utilized to generate high-energy electron or X-ray beams for radiation therapy, specifically in the treatment of cancer.
The main products of LINAC devices include high-energy, low-energy, and medium-energy devices. A high-energy linear accelerator (LINAC) operates at energies ranging from 20 to 50 million electron volts (MeV). It is used to produce high-energy X-rays or electron beams for radiation therapy, particularly for treating tumors located deep within the body. Linear accelerator and non-dedicated linear accelerator methods are employed in the treatment of various cancers such as breast cancer, colorectal cancer, head and neck cancer, lung cancer, prostate cancer, and others. These devices find application in clinics, hospitals, and research centers.
The LINAC devices market consists of sales of an electron generation component, beam transport equipment, radiotherapy equipment, imaging and monitoring accessory. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. LINAC Devices Market Characteristics
3. LINAC Devices Market Supply Chain Analysis
4. Global LINAC Devices Market Trends and Strategies
5. LINAC Devices Market Analysis of End Use Industries
7. Global LINAC Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global LINAC Devices Total Addressable Market (TAM) Analysis for the Market
9. LINAC Devices Market Segmentation
10. LINAC Devices Market Regional and Country Analysis
11. Asia-Pacific LINAC Devices Market
12. China LINAC Devices Market
13. India LINAC Devices Market
14. Japan LINAC Devices Market
15. Australia LINAC Devices Market
16. Indonesia LINAC Devices Market
17. South Korea LINAC Devices Market
18. Taiwan LINAC Devices Market
19. South East Asia LINAC Devices Market
20. Western Europe LINAC Devices Market
21. UK LINAC Devices Market
22. Germany LINAC Devices Market
23. France LINAC Devices Market
24. Italy LINAC Devices Market
25. Spain LINAC Devices Market
26. Eastern Europe LINAC Devices Market
27. Russia LINAC Devices Market
28. North America LINAC Devices Market
29. USA LINAC Devices Market
30. Canada LINAC Devices Market
31. South America LINAC Devices Market
32. Brazil LINAC Devices Market
33. Middle East LINAC Devices Market
34. Africa LINAC Devices Market
36. LINAC Devices Market Competitive Landscape and Company Profiles
37. LINAC Devices Market Other Major and Innovative Companies
40. LINAC Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
LINAC Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses linac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for linac devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The linac devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: High Energy; Medium Energy2) By Application: Breast Cancer; Colorectal Cancer; Head And Neck Cancer; Lung Cancer; Prostate Cancer; Other Applications
3) By End User: Clinics; Hospitals
Subsegments:
1) By High Energy: Linear Accelerators For Radiation Therapy; Electron LINACs; Photon LINACs2) By Medium Energy: Medium Energy Photon LINACs; Compact LINAC Systems
Companies Mentioned: Elekta AB; Varian Medical Systems Inc; Siemens Healthineers GmbH; Hitachi Ltd; Mitsubishi Heavy Industries Ltd; Sumitomo Heavy Industries Ltd; Shinva Medical Instrument Co Ltd; Huiheng Medical Inc; IBA SA; Mevion Medical Systems Inc; ViewRay Technologies Inc; Advanced Oncotherapy PLC; RefleXion Medical Inc; ProNova Solutions LLC; Panacea Medical Technologies Pvt Ltd; Best Theratronics Ltd; P-Cure Ltd; Accuray Incorporated; CGN Dasheng Electron Accelerator Technology Co Ltd; Nordion Inc; Theragenics Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this LINAC Devices market report include:- Elekta AB
- Varian Medical Systems Inc
- Siemens Healthineers GmbH
- Hitachi Ltd
- Mitsubishi Heavy Industries Ltd
- Sumitomo Heavy Industries Ltd
- Shinva Medical Instrument Co Ltd
- Huiheng Medical Inc
- IBA SA
- Mevion Medical Systems Inc
- ViewRay Technologies Inc
- Advanced Oncotherapy PLC
- RefleXion Medical Inc
- ProNova Solutions LLC
- Panacea Medical Technologies Pvt Ltd
- Best Theratronics Ltd
- P-Cure Ltd
- Accuray Incorporated
- CGN Dasheng Electron Accelerator Technology Co Ltd
- Nordion Inc
- Theragenics Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.96 Billion |
| Forecasted Market Value ( USD | $ 8.48 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
